Paul Burton is Chief Medical Officer of Moderna, Inc.. Currently has a direct ownership of 954 shares of MRNA, which is worth approximately $51,859. The most recent transaction as insider was on Nov 07, 2022, when has been sold 192 shares (Common Stock) at a price of $158.68 per share, resulting in proceeds of $30,466. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 954
0% 3M change
0% 12M change
Total Value Held $51,859

Paul Burton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 07 2022
SELL
Open market or private sale
$30,466 $158.68 p/Share
192 Reduced 16.75%
954 Common Stock
Nov 04 2022
BUY
Exercise of conversion of derivative security
-
402 Added 25.97%
1,146 Common Stock
Aug 08 2022
SELL
Open market or private sale
$160,112 $185.1 p/Share
865 Reduced 53.76%
744 Common Stock
Aug 05 2022
BUY
Exercise of conversion of derivative security
$312,436 $194.18 p/Share
1,609 Added 50.0%
1,609 Common Stock
Paul Burton

Paul Burton

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA